医学
纸牌密码算法
倾向得分匹配
冲程(发动机)
脑出血
颈动脉支架置入术
支架
观察研究
内科学
外科
放射科
缺血性中风
颈动脉内膜切除术
缺血
颈动脉
改良兰金量表
蛛网膜下腔出血
机械工程
工程类
作者
Luís Henrique de Castro-Afonso,Felipe Padovani Trivelato,Eduardo Wajnberg,Eduardo Waihrich,Thiago Giansante Abud,Saulo Villas Boas Alves,Anderson Matsubara,Marco Túlio Salles Rezende,João Francisco Santoro Araújo,Guilherme Seizem Nakiri,Daniel Giansante Abud
标识
DOI:10.1177/15910199251342439
摘要
Introduction Thrombectomy has become the standard treatment for acute ischemic stroke (AIS) caused by large vessel occlusions (LVOs). The Aperio Hybrid (Acandis, Pforzheim, Germany) is a new stent retriever designed to enhance the effectiveness of this treatment. However, this new stent has not yet been compared to other thrombectomy devices in a clinical setting. The aim of this study was to compare the Aperio Hybrid ® with the Solitaire™ FR/X (Medtronic, Minneapolis, USA) during thrombectomy in patients with AIS due to anterior circulation LVO. Materials and methods We analyzed data from a multicenter registry of thrombectomy for anterior circulation LVO. Patients with carotid/M1 or proximal M2 occlusions who underwent thrombectomy with either the Aperio Hybrid ® or Solitaire™ FR/X ® were compared using propensity-score matching (PSM). The primary outcome was the recanalization rate, measured by the Treatment in Cerebral Ischemia (TICI) score of 2b-3, while the secondary outcome was the rate of symptomatic intracranial hemorrhage (sICH). Results Among 455 patients treated, after PSM, 258 patients (129 per group) were analyzed. The adjusted recanalization rates (TICI 2b-3) for the Aperio Hybrid and Solitaire FR/X were 79.8% and 75.9%, respectively ( p = .08), while the adjusted sICH rates were 6.9% and 6.2%, respectively ( p = .80). Conclusions In this observational study on thrombectomy for AIS, the Aperio Hybrid and Solitaire FR/X demonstrated similar rates of recanalization and symptomatic intracranial hemorrhage. However, due to significant selection bias, these results should be interpreted with caution.
科研通智能强力驱动
Strongly Powered by AbleSci AI